It is found that JAK2-STAT3 and SMO-GLI1/tGLI1 pathways are simultaneously activated in triple-negative breast cancer (TNBC) and HER2-enriched breast cancer [96]. This evidence concerns the gene JAK2 and breast carcinoma.